About the Authors
- Sonia M. Rosenfield
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Emma T. Bowden
-
Affiliation MedImmune, Gaithersburg, Maryland, United States of America
- Shani Cohen-Missner
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Krissa A. Gibby
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Virginie Ory
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Ralf T. Henke
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Anna T. Riegel
-
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
- Anton Wellstein
-
* E-mail: wellstea@georgetown.edu
Affiliation Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States of America
Competing Interests
Dr. Wellstein is named as an inventor on Georgetown University owned patents related to pleiotrophin and ALK. Dr. Bowden is an employee at Medimmune Gaithersburg. This does not alter the authors′ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Performed the experiments: SMR ETB SCM KAG VO RTH. Analyzed the data: SMR ETB SCM ATR AW. Wrote the paper: SMR ETB ATR AW.